Search This Blog

Sharon Smith

Ozempic Shortage; New MS Framework; and AI in Drug Trials

Get link
Facebook
Twitter
Pinterest
Email
Other Apps

December 01, 2022

The top 3 things you should know to start your day.
3 Things to Know Today

source https://www.medscape.com/viewarticle/984741?src=rss

Get link
Facebook
Twitter
Pinterest
Email
Other Apps

Comments

Alopecia Areata: Late Responses to JAK Inhibitors Reported

April 15, 2024

Response curves have continued to climb for as long as patients are followed, allowing many with disappointing early results to catch up, according to data presented at the AAD meeting. MDedge News source https://www.medscape.com/s/viewarticle/alopecia-areata-some-patients-have-late-responses-jak-2024a100073l?src=rss

CVS Health Cuts 5000 Jobs as Part of Restructuring Plan

August 03, 2023

CVS Health said on Wednesday it has eliminated about 5000 non-customer-facing roles as it seeks to rein in costs after a recent spree of acquisitions. Reuters Health Information source https://www.medscape.com/s/viewarticle/995073?src=rss

FDA approves topical treatment for junctional, dystrophic EB

December 25, 2023

This is the first approved treatment for wounds associated with JEB and the second for patients with DEB, following the approval of a topical gene therapy in May 2023. MDedge News source https://www.medscape.com/s/viewarticle/fda-approves-topical-treatment-junctional-dystrophic-2023a1000wlt?src=rss